| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
REPRODUCTION-DEVELOPMENT |
Requires the Activation of the p38 MAPK Pathway
Perinatal Research and Developmental Pharmacology Unit (F.D.-B.) and Terry Fox Molecular Oncology Group (A.E.K.), Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada; and Departments of Experimental Medicine (F.D.-B.), Oncology (A.E.K.), Cell Biology and Anatomy (F.D.-B.), Microbiology and Immunology (A.E.K.), McGill University, Montréal, Québec H36 1Y6, Canada
Address all correspondence and requests for reprints to: Dr. Florence Doualla-Bell, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Chemin de la Côte-Ste-Catherine, Montréal, Québec H3T 1E2, Canada. E-mail: fdoualla{at}ldi.jgh.mcgill.ca
PGs are regulators of a plethora of uterine functions during
reproductive processes, including uterine contractility. In bovine
uterus, the rate-limiting step in PG synthesis is catalyzed by the PG
endoperoxide G/H synthase (PGHS) enzymes. It has previously been
established that PGHS-2 isoform expression is affected by the
ruminant-specific interferon (IFN)-
in bovine endometrial cells.
Here, we show that PGHS-2 mRNA and protein levels are induced by
IFN-
in primary cell cultures from bovine myometrium. Treatment with
recombinant bovine IFN-
induces the activation of the JAK-STAT and
p38 MAPK pathways in bovine myometrial cells. Inhibition of the p38
pathway by the specific inhibitor SB203580 strongly decreases PGHS-2
mRNA and protein expression without affecting the phosphorylation and
DNA-binding of transcription factors STAT-1 and STAT-2. The p38 pathway
regulates PGHS-2 expression at the posttranscriptional level, because
the presence of SB203580 results in the destabilization of
IFN-
-induced PGHS-2 mRNA. Taken together, these data demonstrate the
ability of IFN-
to induce the activation of the JAK-STAT pathway in
a manner similar to other types of IFN (i.e.
, ß,
and
) and to regulate PGHS-2 mRNA stability through the activation
of the p38 pathway. These findings provide new insights into
the physiological function of IFN-
, in regard to regulation of
specific genes associated with myometrial contractility.
This article has been cited by other articles:
![]() |
Y. Li, S. Batra, A. Sassano, B. Majchrzak, D. E. Levy, M. Gaestel, E. N. Fish, R. J. Davis, and L. C. Platanias Activation of Mitogen-activated Protein Kinase Kinase (MKK) 3 and MKK6 by Type I Interferons J. Biol. Chem., March 18, 2005; 280(11): 10001 - 10010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Z. Wang and R. M. Roberts Interaction of Stress-Activated Protein Kinase-Interacting Protein-1 with the Interferon Receptor Subunit IFNAR2 in Uterine Endometrium Endocrinology, December 1, 2004; 145(12): 5820 - 5831. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guzeloglu, P. Subramaniam, F. Michel, and W. W. Thatcher Interferon-{tau} Induces Degradation of Prostaglandin H Synthase-2 Messenger RNA in Bovine Endometrial Cells Through a Transcription-Dependent Mechanism Biol Reprod, July 1, 2004; 71(1): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Shorts, C. E. Dancz, J. W. Shupp, and C. H. Pontzer Characterization of N-Terminal Interferon {tau} Mutants: P26L Affords Enhanced Activity and Lack of Toxicity Experimental Biology and Medicine, February 1, 2004; 229(2): 194 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, A. Sassano, B. Majchrzak, D. K. Deb, D. E. Levy, M. Gaestel, A. R. Nebreda, E. N. Fish, and L. C. Platanias Role of p38{alpha} Map Kinase in Type I Interferon Signaling J. Biol. Chem., January 9, 2004; 279(2): 970 - 979. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |